Approval · Notice of Compliance 23918 · 2020
TARO-FENOFIBRATE E: Notice of Compliance 23918
Issued July 16, 2020
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 23918
- Date
- July 16, 2020
- Company
- Sun Pharma Canada Inc.Brampton, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to an Abbreviated New Drug Submission (SANDS), supplement
- Submission class
- Other
- Reason
- Change in specifications, Product name change, Revisions to the Product Monograph and inner and outer labels.
- Canadian reference product
- LIPIDIL EZ (Fournier Pharma Inc)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| TARO-FENOFIBRATE E | 02454696 | Marketed |
Medicinal ingredients
- FENOFIBRATE 145 MG per TAB